Frontiers in oncology
An analysis of FDA drug approvals for oncological hematological malignancies in relation to companion diagnostics.
Jan Trøst Jørgensen
Published: 202510.3389/fonc.2025.1635491
No abstract available for this study.
Jan Trøst Jørgensen
No abstract available for this study.